B2AP34 Stock Overview
Credicorp Ltd. provides various financial, insurance, and health services and products primarily in Peru and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 3/6 |
Financial Health | 4/6 |
Dividends | 4/6 |
Credicorp Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$70.14 |
52 Week High | US$72.52 |
52 Week Low | US$54.89 |
Beta | 1.1 |
1 Month Change | -2.15% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 16.04% |
Recent News & Updates
Recent updates
Shareholder Returns
B2AP34 | BR Banks | BR Market | |
---|---|---|---|
7D | 0% | 1.3% | 1.2% |
1Y | n/a | 20.9% | 17.9% |
Return vs Industry: Insufficient data to determine how B2AP34 performed against the BR Banks industry.
Return vs Market: Insufficient data to determine how B2AP34 performed against the BR Market.
Price Volatility
B2AP34 volatility | |
---|---|
B2AP34 Average Weekly Movement | n/a |
Banks Industry Average Movement | 4.4% |
Market Average Movement | 4.7% |
10% most volatile stocks in BR Market | 8.8% |
10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: B2AP34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine B2AP34's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1889 | 37,380 | Gianfranco Piero Ferrari de Las Casas | www.grupocredicorp.com |
Credicorp Ltd. provides various financial, insurance, and health services and products primarily in Peru and internationally. It operates through Universal Banking, Insurance and Pensions, Microfinance, and Investment Banking and Equity Management segments. The Universal Banking segment grants various credits and financial instruments to individuals and legal entities; and various deposits and current accounts.
Credicorp Ltd. Fundamentals Summary
B2AP34 fundamental statistics | |
---|---|
Market cap | R$67.93b |
Earnings (TTM) | R$6.68b |
Revenue (TTM) | R$22.20b |
10.2x
P/E Ratio1.5x
P/B RatioIs B2AP34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
B2AP34 income statement (TTM) | |
---|---|
Revenue | S/16.18b |
Cost of Revenue | S/157.13m |
Gross Profit | S/16.03b |
Other Expenses | S/11.16b |
Earnings | S/4.87b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
Earnings per share (EPS) | 61.20 |
Gross Margin | 99.03% |
Net Profit Margin | 30.07% |
Debt/Equity Ratio | 114.6% |
How did B2AP34 perform over the long term?
See historical performance and comparison